Fast Spiking Parvalbumin Interneurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Fast-spiking parvalbumin (PV+) interneurons constitute a major class of cortical inhibitory neurons that play essential roles in regulating network excitability, timing precision, and gamma oscillations (30-80 Hz). These neurons account for approximately 40% of cortical interneurons and are critical for maintaining the excitation-inhibition balance essential for proper brain function[1].
In neurodegenerative diseases, PV+ interneurons are particularly vulnerable, and their dysfunction contributes to network hyperexcitability, cognitive deficits, and circuit-level pathology in Alzheimer's disease (AD), Parkinson's disease (PD), epilepsy, and various forms of dementia[2].
Parvalbumin (PV) interneurons are fast-spiking cortical inhibitory neurons:
Characteristic electrophysiology:
PV+ interneurons express a distinctive genetic signature:
PV+ interneurons exhibit two primary morphological subtypes:
Basket Cells
Chandelier Cells (Axo-axonic)
PV+ interneurons exhibit the fastest firing rates among cortical interneurons:
PV+ interneurons are essential for generating gamma-frequency oscillations:
PV+ interneurons exhibit profound vulnerability in AD:
Cell Loss
Amyloid Effects
Circuit Dysfunction
Tau Pathology
Therapeutic Implications
PV+ dysfunction contributes to PD pathophysiology:
Dopaminergic Modulation
Network Effects
L-DOPA-Induced Dyskinesias
Olfactory Deficits
PV+ interneurons are critically involved in epilepsy:
Seizure Generation
Therapeutic Targeting
PV+ deficits are a hallmark of schizophrenia:
GABA Synthesis Deficit
Cognitive Deficits
Developmental Hypothesis
GABAergic Modulators
Ion Channel Targets
Optogenetics
Transcranial Stimulation
PV+ neuronal dysfunction markers:
Rudy B, et al. Three groups of interneurons in the neocortex. Progress in Brain Research. 2011. 2011. ↩︎
Palop JJ, Mucke L. Network abnormalities and interneuron dysfunction in Alzheimer disease. Nature Reviews Neuroscience. 2016. 2016. ↩︎
Hu H, et al. Fast-spiking parvalbumin interneurons are crucial for gamma network coherence. Nature. 2014. 2014. ↩︎
[Rudy B, McBain CJ. Kv3 channels: Voltage-gated K+ channels designed for high-frequency repetitive firing. Trends in Neurosciences. 2001](https://doi.org/10.1016/S0166-2236(00). 2001. ↩︎
Tricoire L, et al. A blueprint for the spatiotemporal origins of mouse hippocampal interneuron diversity. Journal of Neuroscience. 2011. 2011. ↩︎
Markram H, et al. Interneurons of the neocortex. Cell. 2004. 2004. ↩︎
[Somogyi P. Synaptic organization of GABAergic neurons in the neocortex. Progress in Brain Research. 2007](https://doi.org/10.1016/S0079-6123(06). 2007. ↩︎
Kawaguchi Y, Kondo S. Parvalbumin, somatostatin and cholecystokinin as chemical markers for nonpyramidal hippocampal neurons. Journal of Comparative Neurology. 2002. 2002. ↩︎
Gonzalez-Burgos G, Lewis DA. GABA neurons and the mechanisms of network oscillations. Neuropsychopharmacology. 2008. 2008. ↩︎
Erisir A, et al. Function of specific Kv2.1 and Kv3.1 subunits in hippocampal pyramidal neurons. Nature Neuroscience. 1999. 1999. ↩︎
Gibson JR, et al. Distinct physiological mechanisms underlie altered GABAergic synaptic transmission in pyramidal neurons and interneurons. Cerebral Cortex. 2005. 2005. ↩︎
Buzsáki G, Wang XJ. Mechanisms of gamma oscillations. Annual Review of Neuroscience. 2012. 2012. ↩︎
Fries P. A mechanism for cognitive dynamics: Neuronal communication through neuronal coherence. Trends in Cognitive Sciences. 2005. 2005. ↩︎
Colgin LL, Moser EI. Gamma oscillations in the hippocampus. Physiology. 2010. 2010. ↩︎
[K和中 K. Functional microcircuit of the primary visual cortex. Neuroscience Research. 2001](https://doi.org/10.1016/S0168-0102(01). 2001. ↩︎
Verret L, et al. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell. 2012. 2012. ↩︎
Palop JJ, et al. Aberrant excitatory network activity and its modification in an Alzheimer's disease mouse model. Nature Neuroscience. 2013. 2013. ↩︎
Zabel M, et al. GABAergic dysfunction in Parkinson's disease. Neurochemistry International. 2012. 2012. ↩︎
Treves EA, et al. Seizure suppression via optogenetic modulation of parvalbumin interneurons. Nature Neuroscience. 2013. 2013. ↩︎
Lewis DA, Hashimoto T. Deciphering the pathogenesis of schizophrenia: The GABA system. Annals of Neurology. 2007. 2007. ↩︎
Brown J. Targeting Kv3 potassium channels for the treatment of epilepsy. Expert Opinion on Therapeutic Targets. 2006. 2006. ↩︎
Hoy KE, Fitzgerald PB. Brain stimulation in the treatment of schizophrenia. Human Psychopharmacology. 2012. 2012. ↩︎
Sturgill JF, et al. Optogenetic mapping in mouse brain slices. Current Protocols. 2014. 2014. ↩︎
Yoshiyama Y, et al. Synaptic alterations in the transentorhinal cortex in PSP and AD. Acta Neuropathologica. 2007. 2007. ↩︎
Gleichmann M, et al. GABAergic activity as a therapeutic target in Alzheimer's disease. Neurobiology of Disease. 2012. 2012. ↩︎